Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Launch of CSR programme

13 Mar 2012 07:00

RNS Number : 2001Z
Cello Group plc
13 March 2012
 



13 March 2012

 

Cello Group plc

 

Launch of CSR programme

 

Cello Group plc (AIM:CLL, 'Cello', or 'the Group'), the insight and strategic marketing group, has today launched its new Corporate Social Responsibility programme 'Talking Taboos'. 

 

Talking Taboos is a campaigning brand that aims to directly tackle health and social issues using Cello's experience and resources in the healthcare space. It will focus on areas where embarrassment, fear or ignorance prevents sufferers from seeking help.

 

For 2012, Talking Taboos will be addressing teen mental health, specifically self-harm, through an extensive research project with the teen charity YoungMinds. The research will examine the context in which teenagers find themselves when actively self-harming, and will attempt to inform parents, teachers, peers and health professionals how best to identify and support at-risk and self-harming teens.

Each Cello Group company will utilise its expertise in methodology or market sector to contribute to a 'whole community' view that will help carers and sufferers by providing context, exploding myths and challenging prevailing attitudes to self-harm. The programme is being led by Vincent Nolan, Group Chairman of Cello Research and Consulting, and the Group is planning to expand this initiative in the future to assist organisations which address a range of health related issues.

Mark Scott, Cello Group CEO, said:

 

"Talking Taboos is a great opportunity for us to support a worthwhile cause in the best way we know how - through our market leading research and our wealth of experience in working with health issues.

 

"It is also an ideal way for our companies to demonstrate their abilities and talents and work across the group to deliver a comprehensive project that should help change the way that self-harm is perceived and handled."

 

 

Enquiries:

 

Cello Group plc (www.cellogroup.com)

Mark Scott, Chief Executive

020 7812 8460

Mark Bentley, Group Finance Director

Vincent Nolan, Group Chairman - Cello Research and Consulting

020 7655 9900

Cenkos

Bobbie Hilliam

020 7397 8900

College Hill

Kay Larsen/Rozi Morris

020 7457 2020

 

 

Notes to Editors (www.cellogroup.com)

 

Cello is an insight and strategic marketing group.

 

The Group's strategy is to create value for shareholders by building an international research and consulting business able to advise blue chip clients globally, along with a marketing business capable of delivering world class solutions.

 

Cello has annualised revenues in excess of £130m, annualised gross profit in excess of £65m and employs over 700 professional staff.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAGGUUWWUPPGMP
Date   Source Headline
14th Sep 20167:00 amRNSInterim Results
9th Sep 20163:45 pmRNSBlock listing Interim Review
31st Aug 20162:29 pmRNSTotal Voting Rights
2nd Aug 201610:50 amRNSTotal Voting Rights
26th Jul 20167:00 amRNSPRE CLOSE TRADING STATEMENT
30th Jun 201610:19 amRNSTotal Voting Rights
20th Jun 20163:14 pmRNSDirector/PDMR Shareholding
3rd Jun 20162:42 pmRNSAdditional Listing and Total Voting Rights
31st May 20168:58 amRNSTotal Voting Rights
20th May 20162:33 pmRNSReplacement: Director/PDMR Shareholding
20th May 20161:30 pmRNSDirector/PDMR Shareholding
18th May 201612:12 pmRNSGrant of Options
16th May 20167:00 amRNSVAT Update
10th May 20163:30 pmRNSResult of AGM
10th May 20167:00 amRNSAGM Statement
29th Apr 20167:00 amRNSTotal Voting Rights
15th Apr 20165:03 pmRNSAnnual Report and notice of AGM
1st Apr 20169:02 amRNSTotal Voting Rights
23rd Mar 20164:21 pmRNSVAT Update
17th Mar 20167:00 amRNSPreliminary Results
1st Mar 201612:52 pmRNSBlocklisting Interim Review
29th Feb 201612:05 pmRNSTotal Voting Rights
29th Feb 20169:57 amRNSAdoption of Financial Reporting Standard (FRS) 101
10th Feb 20163:58 pmRNSHolding(s) in Company
29th Jan 20169:33 amRNSTotal Voting Rights
27th Jan 20167:00 amRNSPRE CLOSE TRADING STATEMENT
30th Oct 20159:25 amRNSTotal Voting Rights
8th Oct 20151:11 pmRNSAdditional Block Listing
30th Sep 20151:15 pmRNSTotal Voting Rights
28th Sep 20152:39 pmRNSHolding(s) in Company
23rd Sep 20152:20 pmRNSHolding(s) in Company
16th Sep 20154:55 pmRNSInterim Dividend Timetable
16th Sep 20157:00 amRNSInterim Results
28th Aug 201510:46 amRNSTotal Voting Rights
12th Aug 201511:57 amRNSBlocklisting Interim Review
31st Jul 201510:13 amRNSTotal Voting Rights
21st Jul 20157:00 amRNSTrading update
1st Jul 20154:20 pmRNSHolding(s) in Company
1st Jul 20151:30 pmRNSTotal Voting Rights
29th May 201511:08 amRNSTotal Voting Rights
15th May 20157:00 amRNSAdditional Listing / TVR
12th May 20151:08 pmRNSResults of Annual General Meeting
12th May 20157:00 amRNSAGM Statement
1st May 201510:43 amRNSTotal Voting Rights
20th Apr 20158:45 amRNSAnnual Report and Accounts 2014 and Notice of AGM
31st Mar 201510:17 amRNSTotal Voting Rights
19th Mar 20157:00 amRNSFinal Results
27th Feb 201511:27 amRNSTotal Voting Rights
9th Feb 20151:34 pmRNSUpdate on potential VAT assessment
2nd Feb 20158:17 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.